(Q48043882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

title

Neuromedin U alters bioenergetics and expands the cancer stem cell phenotype in HER2-positive breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference

neoplastic stem cells

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

Richard K Porter

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

author name string

Vanesa G Martinez

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

John Crown

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

language of work or name

English

0 references

publication date

1 June 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

13 March 2020

number of pages

14

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

volume

140

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

page(s)

2771-2784

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

Cancer metabolism: the Warburg effect today

13 March 2020

cites work

1 reference

Targeting cellular metabolism to improve cancer therapeutics

21 January 2018

1 reference

The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells

21 January 2018

1 reference

Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

21 January 2018

1 reference

Neuromedin U: a multifunctional neuropeptide with pleiotropic roles

21 January 2018

1 reference

Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors

21 January 2018

1 reference

Intracellular distribution of the fluorescent dye nonyl acridine orange responds to the mitochondrial membrane potential: implications for assays of cardiolipin and mitochondrial mass

21 January 2018

1 reference

Versatile functions for IL-6 in metabolism and cancer

21 January 2018

1 reference

Evidence for an alternative glycolytic pathway in rapidly proliferating cells

21 January 2018

1 reference

Metabolic flux and the regulation of mammalian cell growth

21 January 2018

1 reference

Glucose deprivation activates a metabolic and signaling amplification loop leading to cell death

21 January 2018

1 reference

The glucose-deprivation network counteracts lapatinib-induced toxicity in resistant ErbB2-positive breast cancer cells

21 January 2018

1 reference

Neuromedin U elicits cytokine release in murine Th2-type T cell clone D10.G4.1.

21 January 2018

1 reference

Nmur1-/- mice are not protected from cutaneous inflammation

21 January 2018

1 reference

Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population.

21 January 2018

1 reference

Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase

21 January 2018

1 reference

Energy metabolism plasticity enables stemness programs

21 January 2018

1 reference

Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients

21 January 2018

1 reference

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features

21 January 2018

1 reference

Epithelial-mesenchymal transitions in development and disease

21 January 2018

1 reference

Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity

21 January 2018

1 reference

The epithelial-mesenchymal transition generates cells with properties of stem cells

21 January 2018

1 reference

TGF-beta IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

21 January 2018

1 reference

Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance

21 January 2018

1 reference

Overexpression of pyruvate dehydrogenase kinase 3 increases drug resistance and early recurrence in colon cancer

21 January 2018

1 reference

Metabolic and transcriptional profiling reveals pyruvate dehydrogenase kinase 4 as a mediator of epithelial-mesenchymal transition and drug resistance in tumor cells.

21 January 2018

1 reference

Transforming Growth Factor β Mediates Drug Resistance by Regulating the Expression of Pyruvate Dehydrogenase Kinase 4 in Colorectal Cancer

21 January 2018

1 reference

Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells.

21 January 2018

1 reference

An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation

21 January 2018

1 reference

Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion

21 January 2018

1 reference

Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB.

21 January 2018

1 reference

Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.30705

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28340506%20AND%20SRC:MED&resulttype=core&format=json

13 March 2020

1 reference